Nichole Tucker

home / authors / nichole-tucker

Nichole Tucker, MA, is the Web Editor for Targeted Oncology. Tucker received her Bachelor of Arts in Mass Communications from Virginia State University and her Master of Arts in Media & International Conflict from University College Dublin.

Articles

LEAP-010 Study Discontinued for Patients with PD-L1-Expressing HNSCC

LEAP-010 Study Discontinued for Patients with PD-L1-Expressing HNSCC

Nichole Tucker
September 7th 2023

A coprimary end point in the phase 3 LEAP-010 study will not be met.

Latest Updated Articles

2 KOLs are featured in this series.
Published: September 19th 2024 | Updated: September 26th 2024
Final Thoughts: The Importance of Comparative Studies in AD
POLL: What Percent of the Global Population is Estimated to Have Hyperhidrosis?
Published: November 17th 2023 | Updated: May 14th 2025
POLL: What Percent of the Global Population is Estimated to Have Hyperhidrosis?
Test Could Help Identify Patients at Risk for Severe Scleroderma
Published: April 9th 2025 | Updated: May 14th 2025
Test Could Help Identify Patients at Risk for Severe Scleroderma
Artax Presents Phase 2a Results of AX-158 for Plaque Psoriasis
Published: May 9th 2025 | Updated: May 14th 2025
Artax Presents Phase 2a Results of AX-158 for Plaque Psoriasis
POLL: “Lip Flips” or Lip Filler? Analyzing the Latest Trends in Lip Augmentation
Published: February 28th 2025 | Updated: May 14th 2025
POLL: “Lip Flips” or Lip Filler? Analyzing the Latest Trends in Lip Augmentation
CT-P39 is Just as Effective as Omalizumab for Chronic Spontaneous Urticaria Treatment
Published: January 23rd 2025 | Updated: May 14th 2025
CT-P39 is Just as Effective as Omalizumab for Chronic Spontaneous Urticaria Treatment
© 2025 MJH Life Sciences

All rights reserved.